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Summary 
 
 
S.1 Key outcomes 
 
This research is focused on economic differences of emergency vaccination in case of an outbreak of 
Classical Swine Fever (CSF) in a densely populated livestock area in the Netherlands. It compares the ef-
fect of a vaccination to live strategy in which a C-strain vaccine is used with the effects of a E2 subunit 
vaccine. The last vaccine is the preferred vaccine in the current contingency plans. 
 From an economic perspective based on this research the following can be concluded with respect to 
vaccination radius and vaccination strategies: 
- Vaccination in a 2 km radius around infected farms is the preferred strategy compared to 1 or 3 km; 
- C-strain use results in slightly smaller economic effects compared to C2 subunit vaccine in case: 
- Products of C-strain vaccinated animals do not need an additional heat treatment; 
- Of the vaccinated animals only 1 animal per pen of 10 animals has to be tested with PCR; 
- Export markets accept non-vaccinated products from an area/country in which with C-strain vac-
cination has been used as a vaccination to live strategy. 
 
 At present the small economic advantage in the optimal situation of vaccination with C-strain compared 
does not outweigh these constraints and uncertainties.  
 Table S.1 summarises the main economic findings. 
 
Table S.1 Costs of the different control strategies in case of an outbreak of CSF in a DPLA in the 
Netherlands (in million € per outbreak) 
 Control Farmers Total 
  Percentile  Percentile  Percentile 
 Mean 0.05 0.95 Mean 0.05 0.95 Mean 0.05 0.95 
vacE2_1km 35.63 12.13 74.10 12.77 2.57 29.80 48.40 15.40 103.82 
vacE2_2km 27.59 11.18 50.33 17.64 4.93 35.36 45.23 16.56 84.85 
vacE2_3km 25.02 11.05 44.68 23.12 7.65 44.60 48.15 19.66 87.85 
vacC_1km* 32.40 11.91 62.05 10.99 2.63 25.16 43.40 14.70 85.90 
vacC_2km* 26.75 11.43 48.32 15.93 4.44 31.03 42.68 16.73 77.96 
vacC_3km* 25.21 11.14 42.20 21.03 6.90 39.14 46.24 19.31 80.07 
vacC_1kmcul* 75.97 21.73 158.68 9.84 1.65 26.88 85.81 23.76 184.88 
vacC_2kmcul* 108.15 34.20 204.48 11.80 2.32 28.51 119.95 36.76 231.53 
vacC_3kmcul* 140.58 50.76 256.40 14.20 3.19 32.71 154.78 53.64 287.59 
 
  
S.2 Method 
 
In the calculations only those costs are include that are expected to be influenced by the vaccination strat-
egy. These costs and the values used in the calculations can be found in Table 2.2. 
 Not included were enforcement costs and export losses. 
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Samenvatting 
 
 
S.1  Belangrijkste uitkomsten 
 
In dit onderzoek zijn de verschillen in economische effecten van noodvaccinatie bij een uitbraak van Klas-
sieke Varkenspest (KVP) in een veedichtgebied in Nederland onderzocht. Hierbij is een levend vaccin ge-
baseerd op de C-stam vergeleken met het vaccin dat op het moment als voorkeurvaccin genoemd wordt 
in de bestrijdingsdraaiboeken (het E2 subunit vaccin).  
 De resultaten laten zien dat bij toepassing van een 'vaccination-to-live'-strategie:1  
- Bij een vaccinatiecirkel van 2 km rond geïnfecteerde bedrijven is de schade lager dan bij vaccinatie in 
een cirkel van 1 km of 3 km voor zowel C-stam als E2 subunit vaccin 
- Er zijn geringe verschillen tussen de vaccinatiestrategie met C-stam of met E2 subunit vaccin. Dit ge-
ringe verschil in het voordeel van C-stam geldt alleen als er aan een aantal belangrijke voorwaarden 
rond de afzet van producten van gevaccineerde producten is voldaan. Deze randvoorwaarden zijn: 
- Aanvullende hittebehandeling van producten is niet vereist (de huidige regelgeving maakt op het 
ogenblik deze hittebehandeling wel noodzakelijk)); 
- Er hoeft tijdens de eindscreening van de gevaccineerde dieren maar 1 dier per hok van 10 dieren 
onderzocht te worden met de relatieve dure PCR-techniek; 
- Afnemers in het buitenland accepteren (producten van) niet-gevaccineerde dieren uit een regio/land 
waar met C-stam gevaccineerd wordt. 
 
 Op het ogenblik is het onzeker of de beperkte economische voordelen opwegen tegen de vele onze-
kerheden en beperkingen die met de introductie van het C-stam vaccin gepaard gaan. 
 In tabel S1 zijn de belangrijkste resultaten van de berekeningen samengevat. 
 
Tabel S.1 Kosten van de verschillende controlestrategieën in het geval van een uitbraak van KVP 
in een varkensdicht gebied in Nederland (in miljoen € per uitbraak) 
 Controle kosten Kosten veehouders Totaal 
  Percentiel  Percentiel  Percentiel 
 Mediaan 0,05 0,95 Mediaan 0,05 0,95 Mediaan 0,05 0,95 
vacE2_1km 35,63 12,13 74,10 12.77 2,57 29,80 48,40 15,40 103,82 
vacE2_2km 27,59 11,18 50,33 17.64 4,93 35,36 45,23 16,56 84,85 
vacE2_3km 25,02 11,05 44,68 23.12 7,65 44,60 48,15 19,66 87,85 
vacC_1km* 32,40 11,91 62,05 10.99 2,63 25,16 43,40 14,70 85,90 
vacC_2km* 26,75 11,43 48,32 15.93 4,44 31,03 42,68 16,73 77,96 
vacC_3km* 25,21 11,14 42,20 21.03 6,90 39,14 46,24 19,31 80,07 
vacC_1kmcul* 75,97 21,73 158,68 9.84 1,65 26,88 85,81 23,76 184,88 
vacC_2kmcul* 108,15 34,20 204,48 11.80 2,32 28,51 119,95 36,76 231,53 
vacC_3kmcul* 140,58 50,76 256,40 14.20 3,19 32,71 154,78 53,64 287,59 
 
  
S.2 Methode 
 
Bij de berekeningen zijn alleen de kosten die mogelijk verschillen tussen de onderzochte strategieën mee-
genomen (zie tabel 3). In deze berekeningen zijn niet meegenomen de handhavingskosten en de gederfde 
exportinkomsten.  
                                                 
1 De gevaccineerde dieren worden pas geslacht op het einde van hun normale productiecyclus en hun producten worden gekanaliseerd 
binnen Nederland afgezet. 
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1 Setting the scene 
 
 
1.1 Introduction 
 
Epidemic livestock diseases, for example Classical Swine Fever (CSF), present a threat to the productivity 
of the livestock sector and can have substantial effects on national economies. Therefore a rapid detec-
tion and eradication is of utmost importance. In case of an outbreak of CSF the Competent Authorities in 
Europe apply control measures to eliminate the indention from its territory and to avoid spread to other 
member states (MSs).  
 Given the importance of these epidemic livestock disease for MSs and EU economy the EU agreed up-
on a minimal set of measures to be applied in case of an outbreak (Council Directive 2001/89/EC). Espe-
cially in MSs with a large, concentrated and intensive livestock sector the EU minimum measures do not 
lead to a swift and efficient containment of the epidemic and additional measures need to be applied. 
These measures can consist of preventive culling in a circle around infected farms, application of move-
ment restrictions and/or vaccination in an area around infected farms. These specific additional control 
measures can only be applied after approval by the EU commission.  
 To avoid large-scale culling of healthy animals in future outbreaks of CSF the Dutch Government in-
tends to use a 'vaccination-to-live' strategy. To be able to quickly respond in case of an outbreak vaccine 
stocks need to be available. For this arrangements need to be made with potential vaccine suppliers re-
garding type of vaccine and amount of vaccine needed.  
 At the moment, for emergency vaccination against CSF, 2 types of vaccines could be considered to be 
used to control an outbreak of CSF: E2 subunit vaccine and C-strain vaccine.  
 For E2 subunit vaccine diagnostic ELISA-tests can distinguish vaccinated from infected animals. How-
ever, there is some uncertainty whether the future availability of the E2 Elisa test can be ensured.  
 An alternative for the E2 subunit vaccine could be a vaccine based on the C-strain. A problem with C 
strain is that with serological tests it is not possible to distinguish vaccinated from infected animals. To in-
vestigate the presence of viral material a PCR has to be used.  
 In an accompanying study (Backer et al., 2013) the epidemiological effects of control strategies in 
which either E2 subunit vaccine or C strain were used in CSF epidemics were reported. The objective of 
this research is to compare differences in economic effects of control measures between intervention with 
vaccination with a E2 subunit vaccine or a vaccine based on the C-strain.  
 Control measures are associated with costs (see Text box 1). Detection and culling of infected farms, 
preventive culling of high risk farms, movement restrictions to prevent further spread of infection, vaccina-
tion as well as other additional preventive measures are accompanied with substantial costs for govern-
ment as well as the livestock production chain. Besides these direct costs, there are revenues forgone 
(losses) related to export bans and (temporary) loss of export markets within and outside the EU. The 
largest part of theses export losses are related to the fact of an outbreak of CSF and depend only for a 
small part on how the outbreak is controlled. For exporting MSs like the Netherlands, Belgium and Den-
mark these export losses may even be larger than the direct losses of an outbreak. 
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Text box 1 Economic effects of an outbreak of CSF 
When evaluating the economic losses related to an epidemic of a contagious disease, different components can be distin-
guished: 
- Direct costs related to the control of the epidemic  
These include the costs for the infrastructure for the control of the epidemic, the costs associated with culling and de-
stroying of infected and contact animals, the costs associated with destruction of feed on detected farms, and the com-
pensation and vaccination costs. 
- Costs related to trade restrictions 
Due to an epidemic the national and international market access for animals of susceptible species and their products is 
restricted. An epidemic of CSF will result in trade restrictions that are mostly related to the epidemic per se and do not 
depend on the specific characteristics of the control strategy chosen. After the last outbreak it takes time until all the 
restrictions in trade are lifted and the situation from before the epidemic is restored. 
- Ripple effects 
The effects from outbreaks of CSF that are felt upstream and downstream along the livestock value chain: breeding, 
feed production, input supply, slaughter, processing, final sale and consumption. 
- Spill-over effects 
The effects from outbreaks of CSF that are felt in other sectors like tourism. Since other than typical agricultural produc-
tion is becoming more important for the rural economy these spill-over effects are likely to become a large part of the 
total epidemic costs.  
 
 The duration of the trade restrictions has a large effect on the economic consequences for an infected country. For a 
country like the Netherlands, which depends to a large extent on export of pigs and pig meat, the duration of trade re-
striction within and outside the EU from infected areas determine for a large part the economic effects. However these ef-
fects are to a large part determined by the fact of an outbreak and for a smaller part on the way the outbreak is controlled.  
 
 
1.2 Objective of the research 
 
The objective of this research was to get an insight into the economic aspects of application of vaccina-
tion with vaccines based on C strain compared with vaccines based on E2 subunit vaccine in the control of 
an outbreak of CSF in a densely populated livestock area (DPLA) in the Netherlands.  
 The results of this economic study are presented below. These results can support the policy makers 
to make an informed decision on the choice of vaccine type.  
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2 Material and Methods 
 
 
2.1 Epidemiological data 
 
Control strategies 
The epidemiological data as presented in the epidemiological section of the report were used as input for 
the economic calculations (Backer et al., 2013). In total 8 strategies were analysed and the main epidemi-
ological findings are summarised in Table 2.1. Table 2.2 gives an overview of the measures applied in the 
different control strategies.  
 
Table 2.1 Summary of main epidemiological outcomes a) 
control 
strategy 
Duration (days) b) Number of  
detected farms 
Number of pre-emptively 
culled farms 
Number of  
vaccinated farms 
EU 202 (65-475) 40 (10-128) 0 (0-0) 0 (0-0) 
cul_1km 93 (35-199) 13 (5-27) 79 (26-173) 0 (0-0) 
vacE2_1km 136 (45-310) 19 (6-52) 8 (2-20) 98 (20-254) 
vacE2_2km 113 (37-236) 14 (5-32) 8 (2-20) 191 (56-414) 
vacE2_3km 104 (34-203) 12 (5-26) 8 (2-20) 278 (95-588) 
vacC_1km 125 (42-264) 16 (5-41) 8 (2-20) 88 (19-223) 
vacC_2km 101 (36-208) 12 (5-27) 8 (2-20) 175 (51-379) 
vacC_3km 91 (31-185) 10 (4-22) 8 (2-20) 260 (83-515) 
a) Effectiveness of control strategies for default HRPs: epidemic duration, number of detected, pre-emptively culled and vaccinated farms per epidemic; 
median values and (5-95%) interval between brackets; b) Duration of the epidemic is defined as the time between the first and the last detection. 
 
The benchmark strategies 
EU: The EU demands a minimal control strategy, as required by Council Directive 2001/89/EC. All animals 
on infected detected farms are culled, transport is regulated in protection and surveillance zones, and 
dangerous contacts are actively screened and traced.  
 The measures of the EU strategy are always applied; on top of this additional measures are taken in 
the following control strategies: 
- cul1 
Additional pre-emptive depopulation in a 1-km radius around infected premises is a much used strategy 
within the EU in a DPLA.  
- vacE2_Xkm 
Emergency vaccination of finishing pigs and piglets in X (1, 2 or 3) km around infected premises in-
stead of preventive culling. Sows are excluded from vaccination to minimise the risk of persistently in-
fected piglets being undetected. The vaccine strain used is the E2 subunit vaccine. After the outbreak 
vaccinated animals are logistically channelled and slaughtered. The meat of vaccinated animals is used 
for human consumption in the Netherlands. 
- vacC_Xkm 
Emergency vaccination of finishing pigs and piglets in X (1, 2 or 3) km around infected premises in-
stead of preventive culling. Sows are excluded from vaccination to minimise the risk of persistently in-
fected piglets being undetected. The vaccine strain used is C strain. After the outbreak vaccinated 
animals are logistically channelled and slaughtered. The meat of vaccinated animals is used for human 
consumption in the Netherlands.  
- vacC_Xkmcul 
Emergency vaccination of finishing pigs and piglets in X (1, 2 or 3) km around infected premises in-
stead of preventive culling. Sows are excluded from vaccination to minimise the risk of persistently in-
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fected piglets. The vaccine strain used is C strain. After the outbreak vaccinated animals are culled 
and the products of the animals are destroyed.  
 
Economic data used 
Given the objective of the study only the economic differences between the different vaccination strategies 
were evaluated. No estimate was made for the EU strategy or the culling strategy. 
 To evaluate the economic consequences of the different vaccination control strategies, an existing 
economic model is used in Backer et al. (2009). This model is based on partial budgeting since the main 
objective of this research is to compare the effects of different vaccination control strategies. In partial 
budgeting only those costs and benefits that are expected to differ substantially between alternatives are 
included. In the next section the costs that are included or excluded in the model are addressed in more 
detail. Also the used values in the calculations are given. Price data of 2012 were used. In case recent da-
ta are not available (e.g. because some costs can only be determined after an outbreak) they are based 
on historical data indexed for a price level of 2012. For this indexation price indexes of CBS were used.  
 
Table 2.2 Economic input parameters used in the economic evaluation (price level 2012) 
Direct costs 
Operational costs  
Screening and sampling Clearing and disinfection  
Taking samples as suspect 298,684 €/infected farm Sows 502 €/animal 
Execution of screening 244,444 €/infected farm Piglets 0.00  €/animal 
Total screening and sampling 543,128 €/infected farm Fattening pigs 188 €/animal 
Taxation and materials per 
culled farm  
7,180 €/culled farm Vaccination costs  
Destruction (transport included) Sows 0.00 €/animal 
Sows 109 €/animal Piglets 2.26 €/animal 
Piglets 0.00 €/animal Fattening pigs 2.26 €/animal 
Fattening pigs 15 €/animal Test costs    
   Elisa 5,00 €/sample 
   PCR 50,00 €/ sample 
Value loss of vaccinated animals Value of compensated animals including feed 
Piglets 13.25 €/animal Sows 467 €/animal 
Fattening pigs 45.00 €/animal Piglets 45 €/animal 
   Fattening pigs 106 €/animal 
Indirect costs 
Empty farm buildings during outbreak Repopulation costs  
Sows 0.99 €/animal/day Sows 181 €/animal 
Piglets  0.00 €/animal/day Piglets  0.00 €/animal 
Fattening pigs 0.20 €/animal/day Fattening pigs 12 €/animal 
Costs of transportation prohibi-
tion of non-infected farms with fat-
tening pigs, first 6 weeks 
11.01 €/animal    
 
 Short explanation of the different costs included in the calculations: 
- Operational costs 
These are costs related to screening and sampling based on the total cost of the 2001 epidemic in the 
Netherlands (Huirne et al., 2002). These costs occurred in the period from the day of the first outbreak 
until 28 days after the last outbreak.  
- Costs of clearing and disinfection  
The labour costs of culling of animals and disinfection of farms (based on Huirne et al. (2002)). 
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- Compensation for culled pig herds  
The costs of culled animals is the number of culled animals times the value of each animal. The costs 
of destructed feed is the number of culled animals times the average value per animal of the stock of 
feed present on the farm. 
The value of culled animals was based on value tables which are regularly updated.1 Values were calcu-
lated as averages over all ages, since the stage in the production cycle is unknown for individual 
farms.  
- Costs of empty housing  
The costs of empty housing between moment of culling and moment of repopulation after the epidemic 
and a 30-day period after last detection. 
- Costs of culling and disinfection  
The labour costs of culling of animals and disinfection of farms, based on Huirne et al. (2002). 
- Costs of repopulation  
The culled farms incurred costs after repopulation because of suboptimal utilisation of their capacity. 
- Costs of transportation prohibition of non-infected farms and welfare slaughter 
The costs of non-infected farms in an area with a transport prohibition for a 6 week period because of 
missed returns were calculated. Only these costs were calculated for finisher pigs. It is assumed that 
sows will not have welfare problems and will not lose value during a transport prohibition. After 6 
weeks, piglets will be placed within an area within which there are finishing farms that have places 
available because they could slaughter pigs. The value loss compared to animals in non-infected areas 
will be difficult to estimate given the fact that an outbreak of CSF in the Netherlands with its large de-
pendence of export of live piglets will have a detrimental effect on piglet prices.  
- Costs of empty houses and repopulation of non-infected farms in infected compartments 
Replacement pigs are sufficiently available in the Netherlands in the area with movement restrictions to 
prevent empty housing.  
- Costs of vaccinating 
The labour costs of vaccination of animals and the vaccine costs (both E2 as well as C-strain vaccines). 
- Cost of testing  
Test costs vary between the different tests. The laboratory costs of serology2 are estimated at approx-
imately €5 per sample and for PCR for testing of C-strain vaccinated animals at approximately €50 
per sample (Bouma pers. communication). In the initial calculations it is assumed that 10% of the vac-
cinated animals need to be additionally tested (1 animal per pen).  
- Value loss of vaccinated animals 
The value loss of vaccinated animals is the number of vaccinated animals times the average value loss 
of each animal if sold on the Dutch market. The estimates for the value loss of products from vac-
cinated pigs were based on previous research by Van Asseldonk and Bergevoet (2011, unpublished 
data). In the initial calculations it is assumed that the products of vaccinated animals can be sold as 
fresh meat. The impact of additional value loss, in case heat treatment of products is needed for C-
strain vaccinated animals, is discussed in Chapter 4.  
- Costs of logistic processing of vaccinated animals 
During the epidemic and the 30-day period after last detection vaccinated pigs are processed similarly 
to non-vaccinated animals. Vaccinated animals that are still alive after this period, have to be logistical-
ly slaughtered and corresponding costs were calculated. Vaccinated hobby animals were not slaugh-
tered and incurred no additional costs. 
 
                                                 
1 To improve the process of valuation of animals culled during an epidemic the Dutch Competent Authorities and the livestock sector 
agreed upon method for valuation (‘Waardetabellen’). Based on this an annually updated value table prepared by the Agricultural Eco-
nomics Institute (LEI) for different types of animals is created.  
2 E2-ELISA for non-vaccinated animals and Ems for vaccinated animals. 
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Excluded in the calculation 
Export market losses were excluded from the economic analysis. The reason is twofold: 1) it is not likely 
that these losses differ substantially between the evaluated alternatives in this study and 2) it is almost im-
possible to determine these losses unambiguously since the losses are determined by the duration of the 
outbreak, the level of observation (affected area, the Netherlands or the EU) the time horizon of observa-
tion,1 as well as ripple effects. The epidemiological data suggest that the duration of the outbreak for E2 
subunit vaccine and vaccines based on C-strain is almost equal; therefore expected time to resume export 
is almost equal. So export losses are assumed to be similar. Note that the Netherlands is a net exporting 
country of pigs and pork (Table 2.3). Although the export losses are not different between the two evalu-
ated strategies these losses for both strategies are expected to be substantial. 
 
Table 2.3 Export volume of live pigs and pork from the Netherlands in 2012 
 Per week Per year 
Piglets (# animals) 124.505 6.601.710 
Fatteners (# animals) 14.919 3.594.100 
Pork meat in '000 kg 14.919 790.750 
Source: PVE, 2012. 
 
- Enforcement costs were excluded from the calculations. Enforcement costs are costs related to the 
involvement of police, army, customs etc. to ensure compliance with the movement restrictions an ex-
ecution of regulations. The enforcement costs are not likely to be different between the two evaluated 
scenarios. In the previous FMD outbreak in the Netherlands they were estimated to amount to 
€335.484 a day. There are two issues with respect to these enforcement costs:  
- these enforcement costs are not eligible for reimbursement under the EU Veterinary Fund;  
- these costs are difficult to estimate, since they depend on the location of the outbreaks, enforce-
ment deemed necessary by the competent authorities and the expected cooperation of farmers in 
the affected areas.  
 
 Also excluded:  
- Costs that can occur during an epidemic of CSF in not primary affected branches as horses, pigs and 
cattle farming and arable land and the costs of non-agricultural industry as tourism are also not ana-
lysed (i.e. spill-over effects).  
- In this evaluation only the economic effects of the occurrence of the first outbreak in a Densely Popu-
lated Livestock Area (DPLA) are evaluated, the effects of a first outbreak occurs in a Sparsely Populat-
ed Livestock Area (SPPA) are not evaluated. 
 
Best case scenario 
In the calculations presented in Chapter 3 it is assumed that market access is not influenced by the vac-
cine choice. This is for vaccination with the C-strain the best case scenario. In case products originating 
from animals vaccinated with C-strain need additional measures before entering the market, market ex-
cess is denied for a longer time or additional processing of products is needed which has substantial im-
pact on the cost of the strategy. The economic impact of each of those additional measures is addressed 
in Chapter 4.  
                                                 
1 Vrolijk and Poppe (2010) observed that following the CSF outbreak in November 1998 the lowest pork prices since Wold War II were 
observed as a reaction of increased production following the lower production in the Netherlands during the outbreak.  
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3 Results 
 
 
3.1 Total costs and differences between vaccination strategies 
 
In Table 3.1 the control costs (excluding costs borne by farmers), the losses for the farmers as well as the 
total losses are given. The losses borne by farmers include empty farm buildings during outbreak, repopu-
lation costs and the value loss of vaccinated animals. In Figure 3.1 to Figure 3.3 the distribution of the to-
tal losses of the different control strategies are given for the different programme iterations. 
 
Table 3.1 Losses of the different controls strategies in case of an outbreak of CSF in a DPLA in the 
Netherlands (in million € per outbreak) 
 Control Farmers Total 
  Percentile  Percentile  Percentile 
 Mean 0.05 0.95 Mean 0.05 0.95 Mean 0.05 0.95 
vacE2_1km 35.63 12.13 74.10 12.77 2.57 29.80 48.40 15.40 103.82 
vacE2_2km 27.59 11.18 50.33 17.64 4.93 35.36 45.23 16.56 84.85 
vacE2_3km 25.02 11.05 44.68 23.12 7.65 44.60 48.15 19.66 87.85 
vacC_1km* 32.40 11.91 62.05 10.99 2.63 25.16 43.40 14.70 85.90 
vacC_2km* 26.75 11.43 48.32 15.93 4.44 31.03 42.68 16.73 77.96 
vacC_3km* 25.21 11.14 42.20 21.03 6.90 39.14 46.24 19.31 80.07 
vacC_1kmcul* 75.97 21.73 158.68 9.84 1.65 26.88 85.81 23.76 184.88 
vacC_2kmcul* 108.15 34.20 204.48 11.80 2.32 28.51 119.95 36.76 231.53 
vacC_3kmcul* 140.58 50.76 256.40 14.20 3.19 32.71 154.78 53.64 287.59 
*PCR test for 1 animal per pen. 
 
 As can be seen from Table 3.1 and Figure 3.1 the total costs differ substantially between the evaluat-
ed strategies: 
- Vaccination in a circle of 2 km has for all three the evaluated vaccination circles the smallest total 
losses. The share of the losses directly borne by farmer increases when the vaccination radius in-
creases.1 Whereas the cost for the government decreases with increasing diameter when vaccination 
to live strategies are applied.  
- The strategies that involve vaccination with the C strain followed by culling of the vaccinated animals 
have the highest losses.  
- Vaccination strategies that include a vaccination to live strategy are substantially less costly than strat-
egies that involve large-scale culling. For the two vaccine types Vac E2_2km (€45.23m) and 
VacC_2km (€42.68m) have the lowest total losses.  
- The share of the control costs in the total losses is higher in strategies that involve culling of animals. 
In the vaccination to live strategies a large part of the losses are incurred at farm level. These are 
mainly losses related to the value loss due to channelling of vaccinated animals. 
 
 In Figure 3.1 the results of the vacE_1km, vacE_2km and vac E_3km strategies are given. As can be 
seen from Figure 3.1, large differences occur in possible outcomes when iterations are sorted on the 
losses of the outbreak. Losses gradually increase, but at higher percentile values (>0.95) losses rise 
steeply. These are the outbreaks that get out of hand (spread amongst larger regions etc.).The lines of 
the different strategies cross. For example the vacE_1 km strategy for almost 50% of simulated small 
outbreaks has the lowest costs. These are small outbreaks with limited spread from initially infected 
farms. After his point VacE_2km has the smallest losses. Vac E-3km has never the smallest losses. 
                                                 
1 Farmers also participate in the control costs by means of the Animal health fund. Financing mechanisms are discussed in Chapter 4.  
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Figure 3.1 Distribution of outcomes of the simulations for the vacE_1km, vacE_2km and vac 
E_3km. The x-axis gives the percentile and the y-axis total losses in million € 
 
 
 Figure 3.2 compares the losses of the different C-strain strategies. As can be seen from Figure 3.2 
vaccination with the C-strain followed by culling of the vaccinated animals is a costly control strategy. The 
losses increase substantially when the vaccination area increases. 
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Figure 3.2 Distribution of outcomes of the simulations for the different vaccination strategies with 
the C strain. The x-axis gives the percentile and the y-axis total losses in million € 
 
 
Figure 3.3 Distribution of outcomes of the simulations vacE2_2km and VacC_2km. The x-axis gives 
the percentile and the y-axis total losses in million € 
 
 
 Figure 3.3 compares, vacE2_2km, VacC_2km. As can be seen from Figure 3.3 the difference between 
the two strategies is marginal. Also the differences between the two strategies when the outbreak is get-
ting extremely out of hand is (>95% percentile) is relative small.  
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4 Discussion 
 
 
In the discussion the impact of alternative assumptions on the costs of C strain use in comparison with the 
E2 subunit vaccine use will be addressed.  
 
The impact of enforcement costs  
Enforcement costs are mainly affected by the duration of the outbreak and to a smaller extent by the size 
of the outbreak. These costs can be substantial. In previous outbreaks it was estimated to be as high as 
€335.000 per day. However, these costs are very much influenced by policy decisions on how extensive 
the enforcement effort should be. It is expected that in future outbreaks farmers' cooperation will increase 
especially when a vaccination to live strategy will be applied. Furthermore cooperation increases when 1. it 
is clear beforehand what the price of culled animals will be; 2. it is known which arrangements will be in 
place for products of vaccinated animals; and 3. transport of animals to slaughter houses from farms in 
areas with movement restrictions will be possible after a relatively short period. When this is clear before-
hand possible incentives for farmers to move animals illegally from infected to non-infected areas will de-
crease. The amount of enforcement measures and hence the costs per day are determined by the 
confidence of the government in compliance of stakeholders with the movement restrictions.  
 
Export losses and losses related to trade restrictions 
Total effects of the export losses are determined by size and duration of the outbreak, control strategy 
applied and especially the country/area affected. Therefore they vary substantially and can only be deter-
mined after the outbreak.  
 Due to an epidemic the national and international market access for animals of susceptible species and 
their products is restricted. An epidemic of CSF will result in trade restrictions that are to a large extent re-
lated to the epidemic per se and do not depend on the specific characteristics of the control strategy 
chosen.  
 As the last CSF crisis in the Netherlands showed, the effect can be long-lasting. The disrupted produc-
tion during the outbreak in 1997 and the resulting high prices for non-affected farmers increased produc-
tion which led to lowest prices since Wold War II in November 1998 (Vrolijk and Poppe, 2008). So it may 
take several years before the situation from before the epidemic is restored.  
 
Possibility of consumption of products originating from C-strain vaccinated pigs 
From an economic perspective vaccination with the C-strain can only be considered when it is possible to 
apply 'a vaccination to live' strategy. This means strict channelling of the vaccinated animals should be en-
sured and that trade partners show a willingness to accept non-vaccinated animals from a country that 
eradicated an outbreak of CSF with a non-DIVA vaccine.  
 
Compensation by Veterinary Fund and the Dutch Animal Health Fund 
Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field brings together all 
Community financial measures for the eradication, control and monitoring of animal diseases and zoono-
ses. It lays down the relevant procedures governing the Community's financial contribution. Co-financing is 
foreseen in the event of an epidemic livestock disease; typically the MS in which the disease outbreak oc-
curred submits a claim and the Commission then determines the actual reimbursement according to the 
eligibility criteria in place. Council Decision 90/424/EEC allows for co-financing 50% of the costs of com-
pulsory and pre-emptive slaughter and of related operational expenditure (this co-financing is 60% for Foot-
and-Mouth Disease). In Council Decision 90/424/EEC the type of losses covered are described, these are: 
- Costs of compensation to owners the market value of compulsory slaughtered animals or destroyed 
eggs. 
- Costs associated with the compulsory slaughter of animals. 
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- Costs associated with the destruction of carcasses and/or eggs. 
- Costs associated with cleaning, disinfecting, and disinfection of holdings. 
- Costs associated with the destruction of contaminated feed stuffs and/or milk. 
- Costs associated with the destruction of contaminated equipment. 
- In connection with vaccination, eligible expenditures. 
 
 The other 50% of the costs have to be borne by the Member States. In the Netherlands the pig sector 
contributes to the maximum of 26m per 5 year period in the direct costs of outbreaks by means of the 
Dutch Animal Health Fund. Costs related to enforcement of the regulation and value loss of vaccinated an-
imals are not eligible to EU's contribution (or contribution by the Dutch Animal Health Fund).  
 In the case of serious market disturbances due to restrictions imposed by the veterinary authorities in 
the case of outbreaks of animal diseases like FMD or CSF, exceptional market support measures can be 
introduced by the Commission in order to support the farmers affected by these restrictions. The cost 
categories that are eligible for co-financing have recently been specified in more detail in Regulation 
349/2005. These exceptional market support measures are implemented under the authority of DG AGRI. 
Such measures can only be introduced once MSs have introduced the veterinary measures necessary to 
stamp out epizootic diseases, 'only to the extent and for the duration strictly necessary to support the 
market concerned.' 
 
Additional value loss of C-strain vaccinated animals in case a heat treatment of products is required 
The value loss of vaccinated animals in case of E2 vaccination is estimated at €13.25  per piglet and €45 
per fattening pig (Table 2.2). These are the costs due to logistic slaughtering and suboptimal value of 
fresh meat. In case the products of C-strain vaccinated animals have to be heat-treated an additional value 
loss of at least €0.2  per kg have to be considered.1 This results in an additional value loss of 16 € per 
vaccinated animal. For the vacC_2km strategy Backer et al. (2013) estimate that on average 616.000 an-
imals have to be vaccinated of which after the lifting of restrictions about 2/3 are expected to be still pre-
sent (the remaining are slaughtered during the outbreak phase). The additional value loss due to heat 
treatment of products of vaccinated animals is estimated at €6.5m.2  
 
Economic impact of different end-screenings scenarios 
Compared to non-vaccinated farms the test procedure for vaccinated farms involves a more intensive 
screening. There are two options that need to be considered as end-screening strategy: 
1. Testing of a sample size that ensures that the number of undetected sero-positive animals is equal or 
smaller than applying the prescribed end-screening in case of applying EU or Cul 1 strategies. For this 
Backer et al.( 2013) assume a number of 1 animal per pen of vaccinated animals to be tested (this is 
assumed in our initial calculations);  
2. Testing of all vaccinated animals (option 2). 
 
 The additional number of samples and costs related to this for strategy E2_2km and C_2km are given 
in Table 4.1. As this table shows especially in case a vacC_2km is used substantial additional tests costs 
have to be expected due to the high costs for performing a PCR test. 
 
Table 4.1 Test costs during the end-screening 
  option 1  option 2 
 1 animal per pen tested all vaccinated animals tested 
 # of animals (x 1,000) test costs (in million €) # of animals (x 1,000) test costs (in million €) 
vacE2_2km 41 0.21 422 2.11 
vacC_2km 37 1.85 388 19.4 
                                                 
1 Estimate based on Hoste et al. (2007).  
2 2/3 of 616.000 animals * 80 kg slaughter weight *€0.2. 
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5 Conclusions 
 
 
From an economic perspective based on this research the following can be concluded with respect to 
vaccination radius and vaccination strategies: 
- Vaccination in a 2-km radius around infected farms is the preferred strategy compared to 1 or 3 km; 
- C-strain use results in slightly smaller economic losses compared to C2 subunit vaccine in case: 
- Products of C-strain vaccinated animals do not need an additional heat treatment; 
- Of the vaccinated animals only 1 animal per pen has to be tested with PCR; 
- Export markets accept non-vaccinated products from the area with C-strain vaccination. 
 
 At present the small economic advantage in the optimal situation of vaccination with C-strain compared 
does not outweigh these constraints and uncertainties.  
 
 
 20 
Literature  
 
 
Backer, J., R. Bergevoet et al., 2009. Vaccination against Foot-and-Mouth Disease; Differentiating strate-
gies and their epidemiological and economic consequences. Den Haag: LEI, 158. 
 
Backer, J., 2011. Antiviral agents to control Classical Swine Fever epidemics evaluation of control strate-
gies. Report number: 11/CVI0253. 
 
Backer, J., A. Willie and L.A Loeffen, 2013. C-strain vaccination against Classical Swine Fever: effects on 
epidemic and final screening. Concept report.  
 
Huirne, R.B.M., M. Mourits et al., 2002. MKZ: Verleden, Heden en Toekomst; Over de preventie en 
bestrijding van MKZ. Den Haag, LEI: 183  
 
Vrolijk, H.C.J. and K.J. Poppe, 2008. 'Income volatility and income crises in the European Union.' In: Meu-
wissen et al., Income stabilisation in European agriculture, pp. 33-54. Wageningen Academic publishers, 
Wageningen. 
 
 21 
Appendix 1 
Huidige Strategie bestrijding Klassieke Varkenspest (KVP) in Nederland 
 
 
Uitgangspunten 
Uitgangspunt in de draaiboeken KVP is dat er in een cirkel van 2 kilometer rondom besmette bedrijven ge-
vaccineerd gaat worden.  
 Op varkensbedrijven worden op de bedrijven die in de vaccinatiecirkel liggen alle dieren behalve zeu-
gen gevaccineerd. Het betreft vleesvarkens, fokberen, opfokzeugen en zuigende en gespeende biggen. 
De zeugen worden bij KVP niet gevaccineerd. Een bedrijf wordt in principe maar één keer gevaccineerd. 
Indien een bedrijf meerdere keren in een vaccinatiecirkel komt te liggen worden alleen nieuwe/pasgeboren 
dieren die nog niet gevaccineerd waren gevaccineerd en de dieren die bij de eerste vaccinatie jonger dan 
vier weken oud waren. 
 
Maatregelen tijdens de uitbraak 
In de gebieden rondom uitbraken gelden onder andere restricties voor vervoer van en naar locaties met 
gevoelige dieren en wordt ook ander vervoer van agrarische voertuigen zoveel mogelijk beperkt. Zodra 
een besmetting is bevestigd zullen de maatregelen die in de EU-richtlijn genoemd zijn uitgevoerd worden. 
Dit betekent het ruimen van het besmette bedrijf, maar ook het instellen van een beschermingsgebied met 
een straal van tenminste 3 km om het besmette bedrijf. Daarnaast wordt een toezichtsgebied met een 
straal van tenminste 10 km om het besmette bedrijf ingesteld. Indien besloten wordt om te gaan vaccine-
ren zal er een vaccinatiegebied ingesteld worden. In het vaccinatiegebied zijn, op basis van de richtlijn, 
dezelfde maatregelen van toepassing als in het beschermingsgebied en toezichtsgebied.  
 In de draaiboeken worden drie zogenaamde fases onderscheiden. De maatregelen die voor het vacci-
natiegebied in aanvang van kracht zullen zijn (fase 1: geldt van het begin van vaccinatie tot 30 dagen na 
de laatste vaccinatie), zijn identiek aan het maatregelpakket van het beschermingsgebied en toezichtsge-
bied. In de afbouw van de maatregelen worden de maatregelen van fasen 2 en 3 van kracht. Fase 2 gaat 
in na fase 1 en is geldig tot een gunstige uitslag van de screening bekend is, fase 3 gaat in na de scree-
ning en is geldig tot Nederland door de EU vrij wordt verklaard. 
 De maatregelen in fase 2 zijn gelijk aan de maatregelen in fase 1: vatbare dieren mogen met een ont-
heffing vervoerd worden rechtstreeks naar een slachthuis binnen of buiten het vaccinatiegebied. In fase 3 
is het vervoer van vatbare dieren, met ontheffing, toegestaan tussen bedrijven binnen het vaccinatiege-
bied. Het vervoer van vatbare dieren naar een locatie buiten het vaccinatiegebied is verboden, tenzij de 
dieren met ontheffing rechtstreeks naar een slachthuis gaan.  
 Samenvattend: gedurende de uitbraakperiode (fase 1 tot en met fase 3) is er sprake van kanalisatie in 
zowel het vaccinatiegebied, beschermingsgebied en toezichtsgebied van alle gevoelige dieren en hun pro-
ducten uit het gebied (figuur 1). Kanalisatie houdt in dat de producten afzonderlijk herkenbaar bewerkt en 
separaat opgeslagen moeten worden (separaat opslaan zal naar verwachting zulke grote consequenties 
hebben, dat NVWA heeft aangegeven dat duidelijke identificatie voldoende is). 
 
Maatregelen na de uitbraak 
Ook na de uitbraak gelden er nog steeds beperkingen voor de afzet gevaccineerde dieren en hun pro-
ducten. De duur van deze periode met beperking na de uitbraak is afhankelijk van de dierziekte. De inter-
pretatie van de richtlijnen is hieronder weergegeven1 (persoonlijke mededeling: Akkerman, 2009).  
 Voor KVP geldt dat hier onderscheid gemaakt wordt tussen gebruik van levend (niet-marker-) en 
markervaccin. Bij niet-markervaccin geldt dat het vlees gedurende zes maanden (na laatste vaccinatie) een 
hittebehandeling moet ondergaan. Bij gebruik van een markervaccin (art. 19 lid 9 Richtlijn 2001/89/EG) 
                                                 
1 Eén van de speerpunten binnen het EU project 'Animal Health Strategy' is de herziening van de wetgeving voor dierziektebestrijding. 
Hierbij zal zeker de mogelijkheid van vaccinatie als bestrijdingsinstrument, maatregelen tijdens vaccinatie, vermarkten van producten 
en vlees van gevaccineerde dieren herzien worden (meer gericht op de praktijk). 
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gelden andere procedures. In art. 19 lid 8 9 Richtlijn 2001/89/EG staat vermeld dat, in afwijking van lid 5 
en 6, de maatregelen zoals genoemd in art 4 kunnen worden ingetrokken onder genoemde voorwaarden. 
Door dit laatste artikel kan de periode van zes maanden worden verkort. 
 Bij vaccinatie tegen KVP worden op de vermeerderingsbedrijven in de vaccinatiegebieden de aanwezi-
ge biggen met markervaccin gevaccineerd (en de zeugen niet, dit in tegenstelling tot MKZ). De tijdshorizon 
met beperkingen voor afzet van producten van gevaccineerde dieren is begrensd tot de levensduur van de 
gevaccineerde dieren. Er zijn maar een relatief korte tijd gevaccineerde dieren op het bedrijf aanwezig. Na 
ongeveer 70 dagen (de gemiddelde afleverleeftijd van een big naar het vleesvarkenbedrijf) na de laatste 
vaccinatie zullen, bij afwezigheid van verdere vervoersbeperkingen, geen gevaccineerde dieren meer op 
het zeugenbedrijf aanwezig zijn. Op een vleesvarkensbedrijf worden in de vaccinatiegebieden alle aanwe-
zige dieren eenmalig gevaccineerd. Dit betekent dat binnen ongeveer drie maanden deze dieren aan het 
slachthuis geleverd zullen zijn. De maximale duur met beperkingen is dus circa een half jaar (duur van big 
tot met aflevering vleesvarken). 
 
Figuur A.1 Bestrijdingsstrategie / restricties per gebied gedurende en na een KVP-uitbraak 
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